Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03294850 · ClinicalTrials.gov registry record · NA
Biomarkers of Liver Pathology in Patients With Presumed Non-Alcoholic Steatohepatitis Following Bariatric Surgery
A NA study, sponsored by AdventHealth Translational Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT03294850 is a NA study that has completed, run by AdventHealth Translational Research Institute. The registered enrollment target is 14 participants.
The verdict
NCT03294850, a NA study, has completed, sponsored by AdventHealth Translational Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate imaging and other biomarkers of non-alcoholic fatty liver disease before and after bariatric surgery.
Interventions
- PROCEDURE Bariatric surgery
- DEVICE HepQuant SHUNT Dual Cholate Liver Diagnostic Kit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2018-07-18 |
| Est. Completion | 2020-09-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03294850
The ClinicalTrials.gov registry entry for NCT03294850 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AdventHealth Translational Research Institute, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bariatric surgery is the first listed.
NCT03294850 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03294850 about?
NCT03294850 is a clinical study titled "Biomarkers of Liver Pathology in Patients With Presumed Non-Alcoholic Steatohepatitis Following Bariatric Surgery". The purpose of this study is to evaluate imaging and other biomarkers of non-alcoholic fatty liver disease before and after bariatric surgery.
What is the current status of trial NCT03294850?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2018-07-18. Estimated completion is 2020-09-11.
What interventions are being tested in trial NCT03294850?
The interventions under investigation include: Bariatric surgery (PROCEDURE), HepQuant SHUNT Dual Cholate Liver Diagnostic Kit (DEVICE).
Who is sponsoring clinical trial NCT03294850?
This trial is sponsored by AdventHealth Translational Research Institute, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.